TechnoMark News

The market growth can be attributed to several factors such as the increasing prevalence of neuroblastoma in children, improvements in the healthcare infrastructure, and rising R&D activities are anticipated to further contribute to this substantial market growth between 2019 and 2030. However, the high cost of this therapy is likely to restrain the growth of the market to a certain extent. Market Industry Reports (MIR) has published a new report titled “ Pediatric Neuroblastoma Treatment Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the Global Pediatric Neuroblastoma Treatment Market is estimated to account for over US$ 676.0 million by 2019. The market is anticipated to grow at a CAGR of ~8.6% from 2019 to 2030. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes, research centres, and companies. For in...

The market growth can be attributed to several factors such as increasing prevalence of neuroblastoma in children, improvements in the healthcare infrastructure, and rising R&D activities are anticipated to further contribute to this substantial market growth between 2019 and 2030. However, high cost of this therapy is likely to restrain the growth of market to a certain extent. Market Industry Reports (MIR) has published a new report titled " Pediatric Neuroblastoma Treatment Market  - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the Global Pediatric Neuroblastoma Treatment Market is estimated to account for over US$ 676.0 million by 2019. The market is anticipated to grow at a CAGR of ~8.6% from 2019 to 2030. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes, research centers, and companies. For instance, I...